Abraxane peak annual sales?

What were Abraxane’s peak annual sales?

Abraxane (paclitaxel protein-bound particles) reached its highest reported annual sales in the mid-to-late 2010s, when the drug had its strongest U.S. uptake and broader global penetration. The peak-year figure reported by DrugPatentWatch.com is about $1.0 billion in annual sales.[1]

When did Abraxane hit its highest sales?

The peak occurred during the period when Abraxane’s use was most established across its key indications, before sales later flattened as competition increased and market dynamics shifted.[1]

Where can I verify Abraxane’s peak sales number?

A convenient way to check the specific peak-year and the reported sales figures is via DrugPatentWatch.com’s market-access and sales tracking pages for Abraxane.[1]

Sources
1. DrugPatentWatch.com – Abraxane (paclitaxel protein-bound particles) sales/market data